Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema.

  title={Repeat intravitreal triamcinolone acetonide injections in uveitic macular oedema.},
  author={Ahmed B Sallam and Simon R J Taylor and Zohar Habot-Wilner and Mostafa A Elgohary and Helen Hyun-Jin Do and Peter McCluskey and Sue Lightman},
  journal={Acta ophthalmologica},
  volume={90 4},
retreatment only after the sixth month. The design of this compassionate program study provided for retreatment from the fourth month on a PRN basis. Our results show that a sustained effect can be obtained for both functional and anatomical aspects. It is worth remarking that our patients displayed older CRVO forms, with longer ME duration in comparison with the GENEVA trial (13 versus 5 months, respectively), lower mean BCVA at baseline (20 ⁄ 320, versus 20 ⁄ 80, respectively) and higher CFT… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.


Publications citing this paper.
Showing 1-10 of 12 extracted citations


Publications referenced by this paper.
Showing 1-10 of 12 references

Efficacy and safety

TY Wong

Studies investigating repeat IVTA injections in other conditions such as diabetic macular oedema

lar pressure Kok

The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema

B vanKooij, A Rothova, P deVries
Ocul Immunol Inflamm • 2006

Outcome of intravitreal

S Lightman

Similar Papers

Loading similar papers…